Dr Byron Creese
@byroncreese.bsky.social
Senior Lecturer and Director of Research, Department of Psychology | Brunel University of London | Centre for Cognitive and Clinical Neuroscience | Neuropsychiatric Syndromes in #Dementia
Bit of a metalhead as well 🏳️🌈
Bit of a metalhead as well 🏳️🌈
This isn’t promoting more prescribing.
Risperidone should remain a last resort for severe, distressing symptoms.
But since it’s still used, we need clear evidence to guide safer decisions and interpret outcomes accurately.
#DementiaCare #Epidemiology #CVD
Risperidone should remain a last resort for severe, distressing symptoms.
But since it’s still used, we need clear evidence to guide safer decisions and interpret outcomes accurately.
#DementiaCare #Epidemiology #CVD
October 9, 2025 at 8:26 AM
This isn’t promoting more prescribing.
Risperidone should remain a last resort for severe, distressing symptoms.
But since it’s still used, we need clear evidence to guide safer decisions and interpret outcomes accurately.
#DementiaCare #Epidemiology #CVD
Risperidone should remain a last resort for severe, distressing symptoms.
But since it’s still used, we need clear evidence to guide safer decisions and interpret outcomes accurately.
#DementiaCare #Epidemiology #CVD
We expected stroke risk to rise mainly in those with CVD.
Instead, risperidone increased risk across all groups.
Absolute risk was highest in those with CVD, so if stroke occurs post-treatment, it’s likely due to vascular history, not just the drug.
Instead, risperidone increased risk across all groups.
Absolute risk was highest in those with CVD, so if stroke occurs post-treatment, it’s likely due to vascular history, not just the drug.
October 9, 2025 at 8:26 AM
We expected stroke risk to rise mainly in those with CVD.
Instead, risperidone increased risk across all groups.
Absolute risk was highest in those with CVD, so if stroke occurs post-treatment, it’s likely due to vascular history, not just the drug.
Instead, risperidone increased risk across all groups.
Absolute risk was highest in those with CVD, so if stroke occurs post-treatment, it’s likely due to vascular history, not just the drug.
The infographic shows 1-year stroke incidence (findings similar for 12-week):
1️⃣ No stroke history
2️⃣ Stroke history
3️⃣ With CVD / CVD risk factors
4️⃣ Without CVD / CVD risk factors
1️⃣ No stroke history
2️⃣ Stroke history
3️⃣ With CVD / CVD risk factors
4️⃣ Without CVD / CVD risk factors
October 9, 2025 at 8:26 AM
The infographic shows 1-year stroke incidence (findings similar for 12-week):
1️⃣ No stroke history
2️⃣ Stroke history
3️⃣ With CVD / CVD risk factors
4️⃣ Without CVD / CVD risk factors
1️⃣ No stroke history
2️⃣ Stroke history
3️⃣ With CVD / CVD risk factors
4️⃣ Without CVD / CVD risk factors
Just remembered this - just flagging here in case you hadn't seen but I posted the links to the preprints (see my profile)
January 13, 2025 at 8:46 AM
Just remembered this - just flagging here in case you hadn't seen but I posted the links to the preprints (see my profile)
Sure, we should have a preprint up soon! Will post it here when it's available.
November 30, 2024 at 8:41 PM
Sure, we should have a preprint up soon! Will post it here when it's available.